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Traditionally drug discovery has been a labor intensive effort, since it is 
difficult to identify a possible drug candidate from an extremely large small 
molecule library for any given target. Most of the small molecules fail to show 
any activity against the target because of electrochemical, structural and other 
incompatibilities. Virtual screening is an in-silico approach to identify drug 
candidates which are unlikely to show any activity against a given target, thus 
reducing an enormous amount of experimentation which is most likely to end 
up as failures. Important approaches in virtual screening have been through 
docking studies and using classification techniques. Support vector machines 
based classifiers, based on the principles of statistical learning theory have 
found several applications in virtual screening. In this paper, first the theory 
and main principles of SVM are briefly outlined. Thereafter a few successful 
applications of SVM in virtual screening have been discussed. It further 
underlines the pitfalls of the existing approaches and highlights the area which 
needs further contribution to improve the state of the art for application of 
SVM in virtual screening. 
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1. INTRODUCTION  
 Rational drug design is a focused approach to aid traditional drug discovery to reduce experimental 
cost and time. This basically involves identification or creation of candidate drug like molecule using the 
information about the structure of a drug receptor or one of its natural ligands. It includes four essential steps as 
shown in Fig. 1. 
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Identification of potential targets 
 
 
 
Structural study of the target to find its active site 
 
 
 
Finding potential small molecules which can act as drugs against given target 
 
 
 
Synthesis of the proposed plausible candidate 
 
 
 
Pre-clinical trials 
 
 
 
Clinical trials 
 
 
 
Approved drug 
 
Fig. 1 Essential steps of drug discovery procedure 
 
 Virtual screening is basically an approach to search the whole known chemical space with the aid of 
computational techniques. It strives to find novel molecular scaffold which can act as drug against a particular 
given target protein. It focuses on defining the criteria for filtering the large chemical databases and applying 
them to find small molecules with desired properties which can bind to a given drug target and act as a drug. 
Several approaches used for virtual screening includes Hansch analysis, Free-Wilson analysis, Hansch Free-
Wilson mixed approach[1], [2], active site interactions[3] or de novo models[4], [5], 3D-pharmacophore based 
design[6], comparative molecular field analysis CoMFA[7], [8] and molecular docking[9], [10]. Quantitative 
structure activity relationship, QSAR [11], [2] is an approach to rational drug design that is based on the concept 
that the structure and biological properties of a molecule are interrelated. It includes Hansch and Free-Wilson 
analyses. Hansch analysis correlates physicochemical properties to biological activity of a molecule. Free-
Wilson is a numerical method which directly relates structural features with biological properties. Both 
approaches are closely interrelated, theoretically as well as in their practical applications. Thus, both the 
approaches are often used combinatorially where, biological activity due to certain structural modifications are 
calculated using Free-Wilson type parameters and physicochemical parameters are used to describe the effect of 
some other substituent on the biological activity[12]. Basically, in QSAR approach, a molecular structure is 
represented using the computable molecular descriptors (broadly hydrophobic, electronic and steric) to compute 
the biological activity with the equations relating them. These equations are used to calculate the biological 
activity of different synthesized and predicted molecules against a given target to ensure their effectiveness as a 
drug. 
 Pharmacophore can be defined as ―a set of structural features in a molecule that is recognized at a 
receptor site and is responsible for that molecule’s biological activity‖ [13]. Pharmacophore modeling involves 
the following steps that are iteratively performed until a desired result is obtained: Identification of structural 
and chemical features common in biologically active molecules, measurement of three dimensional orientation 
of the common features, defining a pharmacophore, validation of the pharmacophore to be harbored by active 
compounds and not by any inactive compound and refining of the pharmacophore model by applying the same 
to compounds with known functionality. This approach is more useful when the structural information of the 
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target protein in unknown. In [14] and [15] pharmacophore modeling has been used as a tool to screen large 
libraries to find inhibitors of given target. 
 The principal concept underlying Comparative Molecular Field Analysis (CoMFA), is that the 
difference in biological activity of a molecule is due to the changes in shapes and strength of its non-covalent 
interaction (steric and electrostatic) to its surroundings. For CoMFA analysis, a set of molecules is required. 
Each conformation of these molecules is considered to be the active structure, and is placed on the cubic grid to 
calculate its biological activity by finding its surrounding molecular field using appropriate probe. An article 
enunciating a study on epothilones using CoMFA is discussed in [8]. Docking is also an efficient approach to 
rational drug design which tries to ―predict the structure and binding free energy of a ligand receptor complex 
given only the structure of the free ligand and receptor‖ [1]. An automated docking program, DOCK, was 
proposed in [3]. A docking problem can be broken to basic three steps as shown in Fig. 2: (i) defining the 
potential drug target and identification of its active site to which the drug molecule must bind, (ii) modeling a 
drug like small molecule and study of its interaction with the receptor protein, and (iii) performing the 
conformational and orientation search to find low energy states of the system that can correlate to the original 
binding model. 
 
                                            Structural study of the target and its active site 
 
 
                        Studying the interaction between probable drug candidates and the target 
 
 
                     Studying the orientation and conformation of the target inhibitor complex 
 
 
                                                              Predict Binding Affinity 
 
Fig. 2 Steps involved in docking studies 
 
Active site of a protein is a localized combination of amino acid groups within its tertiary (3D) or quaternary 
structure that are capable of interacting with a chemically specific substrate which provides the protein with its 
biological activity. Virtual screening involving active site interactions can be categorized into two groups. The 
first approach strives to find molecules interacting optimally to the active site by searching different databases 
of known small drug like molecules and second, involves building de novo models of ligands complementary to 
a given active site. De novo design can be done in two ways: Outside-in and Inside-out approaches. In Outside-
in approach the binding site is analyzed to determine where specific functional groups might bind properly so 
that these functional groups can be connected to build a real molecule. On the other hand, Inside-out approach 
involves growing a ligand molecule within the given active site using an appropriate search algorithm where 
each proposed ligand is evaluated using an energy function [4], [16], [17]. 
 Several computational concepts have been facilitated for the above mentioned approaches of virtual 
screening. In the present article we would emphasize on the use of support vector machines (SVM) for these 
virtual screening approaches. 
 
2. SUPPORT VECTOR MACHINES  
 Support vector machines was invented by Vapnik et.al.,in 1979 [18], [19], [20]. It is a machine learning 
technique to facilitate classification. Two basic concepts essential for support vector machines are a maximal 
margin classifier and a kernel function. The former is responsible for the construction of a separating hyperplane 
so that the distance between the different classes is maximized. The latter is used to map the data in a new space 
where they are separable. 
 Firstly the SVM is trained using a learning data set. This data set necessarily contains data divided in 
two classes. When these training data are linearly separable the algorithm learns to construct the unique 
hyperplane having the maximal margin (δ) separating the training objects into two classes as show in Fig. 3a. 
However, the data can also be linearly inseparable. In such a scenario the algorithm projects the input data 
vectors to a higher dimensional feature space using kernel functions [20], [21]. Thereafter these projections of 
the data are classified by constructing a hyperplane as shown in Fig. 3b. 
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Fig. 3 (a) Maximum separation hyperplane for linearly separable data, (b) Linear separation in feature space for 
linearly inseparable data. 
 
There are several kernel functions developed for this purpose. A recent review in 2007 delineated the use of 
kernel functions from the perspective of biological and chemical applications. This article vividly discusses the 
necessity and usage of different kernel functions. It states that if a data set can be linearly classified then non-
linear relations should be avoided for its classification. It also shows that overfitting of the training data can 
occur when more complex kernel functions are used. For solving such a problem the author recommends 
comparing SVM models based on non-linear kernel functions with SVM models obtained with a linear kernel 
since the separating hypersurface may be almost linear. In similar fashion the author have discussed and 
explained several rules for kernel selection and comparison of the results of different kernel functions. 
 
3. APPLICATION OF SVM IN VIRTUAL SCREENING 
 Virtual screening basically involves examination of many molecules to find active molecules against a 
given target. This is generally done with the knowledge of the known inhibitors of the given target. If the 
molecular properties of a set of molecule which is active against a target of interest are known then the vast 
chemical space can be searched to fetch such molecules which possess the same properties. If a classifier is 
trained with the molecular properties of the known inhibitors of a given target then the classifier can predict or 
classify other molecules from the chemical databases to active or inactive against the same target. Therefore the 
problem of virtual screening can be well framed as a classification problem. The ability of SVM to successfully 
classify linearly and non linearly separable data has made its application popular in drug design, virtual 
screening and combinatorial chemistry [22], [23], [24], [25], [26], [27]. 
 In [28] the authors have reported results of such an analysis using SVM. Here molecules in five data 
sets were ranked according to their activity against given targets. This approach uses Gaussian kernel and those 
molecular descriptors for which the values of active and inactive molecules lie in different and distinct ranges. 
SVM has also been applied for activity prediction of small molecules other than their classification and ranking. 
 Yao et. al., had proposed an SVM based technique to predict the activity of cyclooxygenase 2 (COX- 
2) inhibitors [29]. The kernel function used for the study was radial basis function. The structure of the 
molecules was described using several molecular descriptors. These include one constitutional descriptor, one 
geometrical descriptor, one topological index, one electrostatic descriptor, and two quantum chemical 
descriptors. Another approach in [30] elucidates the application of SVM for drug-likeness and agrochemical-
likeness prediction to aid virtual screening. It also successfully predicts the activity of several Carbonic 
Anhydrase II (CA II) enzyme inhibitors. The drug and agrolikeness descriptors used for the study are as follows: 
molecular weight, fractional absorption, log of 1-octanol/water partition coefficient at pH 7.4, log of 1-
octanol/water partition coefficient (neutral form), log of water solubility (g/mL) at pH 7.4, number of hydrogen 
bond donors, number of hydrogen bond acceptors, number of rotatable bonds, molecular radius of gyration, 
atomic polarizability, dipole moment, and set of Jurs descriptors. This study demonstrated that SVM with radial 
basis function kernel outperforms SVM with linear kernel, multilayer perceptron, modular feed forward network 
and generalized feed forward network. Though, the usage of drug and agro-likeness descriptors help in 
predicting drug likeness and agrochemical-likeness but the authors have stated that usage of 2D and 3D 
descriptors will improve prediction rate. SVM models are also used for feature selection. In this case the 
algorithm selects the features most essential for the prediction of activity/ druggability/ toxicity/ any other 
property of a set of molecules. Byvatov and Schneider [31] discuss a work that uses SVM for selecting relevant 
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molecular descriptors from a trained classifier which could be important for better understanding of ligand-
receptor interactions. In Muller.et.al.,[32] another SVM based technique for drug-likeness prediction is 
presented. In these types of studies where feature selection and prediction are done together, the classifier is 
trained first using all the features available and then a feature selection algorithm is employed to discard the 
least important features. But the main drawback of this approach is that the classifier assumes a statistical 
distribution the data which may/ may not be a good approximation. Also the feature selection becomes 
dependent on the classification model. Therefore, these issues must always be handled while amalgamating 
feature selection with a prediction/ classification model. 
 In [33] an in silico chemogenomics approach for virtual screening of G-protein coupled receptors has 
been discussed. This is a SVM based approach that uses a flexible framework to incorporate various information 
sources on the biological space of targets and on the chemical space of small molecules. The article also 
investigates the usage of 2D and 3D descriptors for small molecules to gauge the prediction accuracies. It shows 
that the inclusion of the information about the known hierarchical classification of the target family and the 
interacting amino acids in the binding pockets of the target under consideration significantly improves the 
prediction accuracy of the proposed model. 
 Recently a few works delineates a shift from the usual paradigm of virtual screening. These approaches 
use the pair potentials of active and inactive molecules instead of only their molecular descriptors to train the 
SVM. Li et. al., [34] use the same approach to identify EGFR kinase inhibitors. The positive data of the training 
set containes the pair potentials obtained from three-dimensional structures of protein-ligand complexes present 
in PDB. The negative data set constituted of the computed pair potentials of protein-ligand complexes obtained 
by docking a set of randomly chosen 10,000 molecules to EGFR. To further fine tune their results Li et. al., [34] 
compared the binding profile of the predicted active molecules to the binding profile of the known EGFR 
inhibitor, erlotinib. Here, the binding profile is referred to as the off-targets of a molecule occurring in multiple 
signalling pathways. This profile contains the binding affinity of a molecule to different targets spanning over 
several signaling pathways. Using this approach, Li et. al., were able to identify three new inhibitors of EGFR. 
A similar and more improved approach was proposed in [35]. The authors defined new pair potentials based on 
2018 protein-ligand complexes. The negative data set in this case was more intelligently designed. It contained 
the computed pair potentials of the protein-ligand complexes where, the ligands were inactive molecules or 
decoys obtained from Directory of Useful Decoys (DUD). The rationale behind designing such a negative data 
set was to ensure that the SVM can efficiently distinguish between molecules that acquire the binding modes of 
active molecule and not the decoys. These are new approaches to virtual screening using SVM which produces 
promising results but, these approaches are target as well as inhibitor type specific. Therefore, virtual screening 
for different targets requires selection of new set of pair potentials and construction of binding profiles. 
Moreover, amongst these predicted molecules only very few are found to be really active against the given 
target when tested experimentally. Though SVM has lower prediction error in comparison to other classifiers 
but still it needs more endeavor to make more relevant biological predictions. 
 There have also been endeavors in developing new kernel functions which could be more helpful for 
biological predictions. Mostly SVM applications, which are used for virtual screening uses the radial basis 
function. In [36] a novel graph alignment kernel function is proposed, which is used for virtual screening. This 
method uses graphs to represent molecules. Then it applies wavelet analysis on these graphs to capture the local 
topologies of these molecules. The features generated in this way have been further used by the novel graph 
alignment kernel function to build SVM models for virtual screening. A similar approach is also discussed in 
[37] which is an extension or improvement of the former work. Here the kernel function is a bit improved and is 
termed as graph assignment kernel. 
 
4. CONCLUSION  
 The applications discussed in this paper enunciate the effectiveness of the machine learning approaches 
in virtual screening. It has some definitive advantages over random selection. Therefore, it is evident that virtual 
screening can make important contributions to the drug discovery process. The application of machine learning 
is particularly beneficial when the objective is to reduce a large data set to a smaller chemical library. But, it 
must is noticed that the efficiency of these methods completely depends on the quality of the data set being 
used. Feature selection is also important for predictive model building. When feature selection and training of 
the model occurs simultaneously it should be taken care that the statistical distribution of the data has been 
chosen appropriately. 
 Most studies report that the SVM performs better than other machine learning approaches. But, still 
performance of these algorithms needs to be improved. The prediction quality of SVM can often be improved 
by adjusting its parameters to the particular problem. Specifically the kernel function selection for a particular 
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problem is difficult. Therefore, further studies are required to be made for improving the performance of SVM 
in virtual screening particularly. 
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